Moderna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine, the Financial Times ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to ...
Moderna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has been approved ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step ...
If trials are successful, US government likely to buy doses for vaccine stockpile.
Moderna isn't resting on its laurels, though. The company is developing several exciting candidates. Unfortunately, the most ...
Is Pfizer's dividend sustainable, and will it be able to sustain the current $0.42 per quarter dividend pace and also ...
China's CanSino Biologics Inc. has got green light to continue phase-3 trials of its Covid-19 vacci… ...
The facility, which will be the drugmaker's first end-to-end ADC production site, will be supported by the Singapore Economic Development Board. The company did not provide details on the possible ...